Back
Nemak SAB de CV Vs. PTC Therapeutics Industry Stock Comparison
Sell
45
NMAKF
Nemak SAB de CV
Last Price:
0.1600
Seasonality Move:
0.38%
Sell
35
PTCT
PTC Therapeutics
Last Price:
30.99
Seasonality Move:
8.11%
Sell
45
Nemak SAB de CV (NMAKF)
is a Sell
Is Nemak SAB de CV a Buy, Sell or Hold?
- The current Nemak SAB de CV [NMAKF] share price is $0.1620. The Score for NMAKF is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- NMAKF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $31.00. The Score for PTCT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NMAKF Stock Price Chart
What is Nemak SAB de CV's stock price today?
-
The Nemak SAB de CV share price today is $0.1620
The current trend is relatively stagnant and NMAKF is experiencing slight buying pressure.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $31.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTCT is experiencing buying pressure, which is a positive indicator for future bullish movement.
NMAKF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 49.97 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.1501 - 0.1701) | Buy |
Bollinger Bands (100): | (0.1584 - 0.2184) | Sell |
PTCT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.95 | Sell |
Relative Strength Index (14 RSI): | 38.05 | Sell |
Chaikin Money Flow: | 242921 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.07 - 37.67) | Sell |
Bollinger Bands (100): | (26.88 - 35.22) | Sell |
NMAKF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.16 | Buy |
20-day SMA: | 0.16 | Buy |
50-day SMA: | 0.16 | Sell |
200-day SMA: | 0.2 | Sell |
8-day EMA: | 0.16 | Buy |
20-day EMA: | 0.16 | Buy |
50-day EMA: | 0.17 | Sell |
200-day EMA: | 0.2 | Sell |
PTCT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.97 | Sell |
20-day SMA: | 35.08 | Sell |
50-day SMA: | 34.11 | Sell |
200-day SMA: | 27.6 | Buy |
8-day EMA: | 32.46 | Sell |
20-day EMA: | 34.04 | Sell |
50-day EMA: | 33.6 | Sell |
200-day EMA: | 31.79 | Sell |
Nemak SAB de CV Earnings Growth & NMAKF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.53 per share, and an increase next year of $2.47 per share.
Nemak SAB de CV Technical Analysis
Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
PTC Therapeutics Technical Analysis
Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |